EPO Patents = 1

Trademarks = 1

Forward Citations = 5

Loading Chart...

17 inventors (with patents filed for the assignee):

Matthew Robert Warr (3 out of 6 patents)

James Andrew Whitney (3 out of 6 patents)

Henry G Morrison (2 out of 10 patents)

4. Bing Shi (2 out of 40 patents)

5. Ernest A Carra (2 out of 20 patents)

6. Fang Wang (2 out of 26 patents)

7. Dimitrios Stefanidis (2 out of 29 patents)

8. Jeffrey N Hemenway (2 out of 7 patents)

9. Yan Xin (2 out of 5 patents)

10. Brandon H Brown (2 out of 3 patents)

11. Troy Reynolds (2 out of 3 patents)

12. Brian Koh (1 out of 1 patent)

13. Igor Theurl (1 out of 1 patent)

14. Ryan Hansen (1 out of 4 patents)

15. Kenna Lynn Anderes (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. RE49445 - N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide (2023-03-06),

2. 11596637 - CHK1 (SRA737)/PARPi combination methods of inhibiting tumor growth (2023-03-07),

3. RE48285 - N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide (2020-10-26),

4. 10245268 - Treatment of ACVR1-mediated diseases (2019-04-02),

Sierra Oncology is a clinical-stage biopharmaceutical company focused on advancing targeted therapeutics for the treatment of solid tumor patients. Their lead drug candidate, SRA737, is being evaluated in multiple clinical studies for the treatment of various types of cancer. With a dedicated team of researchers and scientists, Sierra Oncology is committed to developing innovative therapies that have the potential to improve outcomes for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#49 in Plymouth, MI

#1,982 in Michigan

#59,049 in US

Plymouth, MI, United States of America

Sierra Oncology, Inc.